WebFounded in February 2003, PluroGen Therapeutics is a start-up pharmaceutical firm that is in the process of developing a topical antimicrobial gel (TAG) to prevent and treat burn and skin-ulcer infections. WebPluroGen Therapeutics Co-Founder University of Virginia Professor of Biomedical Research in the Department of Plastic Surgery Board and Advisor Roles Number of Current Board & …
PluroGen Therapeutics - Overview, News & Competitors - ZoomInfo
WebOct 21, 2008 · PluroGen Therapeutics . As Dr. George Rodeheaver worked in his biomedical-research laboratory at the University of Virginia (U.Va.), he reflected on the achievements of the past 20 years. In the late 1970s, Rodeheaver and his colleagues began work on a drug that would counter burn-related infections. After considerable effort, his team ... WebNov 22, 2010 · PluroGel® is based on technology developed by U.Va. researchers George T. Rodeheaver, Dr. Richard F. Edlich and Sherry Sutton to treat patients with severe burns and wounds and to prevent infection. PluroGel® is unique in that it thickens at body temperature and liquefies at cooler temperatures. phila democratic city committee
PluroGel - PSSD - Plurogen therapeutics LLC
WebPluroGen Therapeutics, LLC. provides clinically advanced and advantaged burn, wound and skin care products. We work closely with doctors, nurses, pat … See more 0 people follow … WebDec 13, 2024 · Plurogen Therapeutics Inc: Plurogen Therapeutics Inc (Plurogen) is a biotechnology company that provides clinically advanced and superior products from its patent-protected technology platforms. The company provides products such as plurogel, a burn and wound product that serves severe burn and non-healing (or chronic) wound … http://plurogen.weebly.com/plurogel---pssd.html phila dept of planning and development